This, in turn, downregulates the tumor suppressor RASSF1, inhibiting apoptosis and leading to HCC development, indicating a detrimental impact of CTLA4 gene polymorphism on HCV-associated HCC cases [25]. Here, CTLA4 is linked to hepatocellular carcinoma.